Skip to main content

The 2024 Global Conference speaker roster is now live and expanding! Explore the growing lineup, with more additions expected before the program release in early April.

Name
What Is the Prognosis for COVID-19 Treatments and Vaccines?

What Is the Prognosis for COVID-19 Treatments and Vaccines?

October 12 at 7:45 am PDT/10:45 am EDT

 

Individuals across the US have adapted to a largely isolated lifestyle due to COVID-19, and many do not expect to return to normalcy until a COVID-19 vaccine is developed. Even with a vaccine, challenges and questions, such as vaccine access and public trust, will remain top of mind. While efforts in vaccine development surge forward, research on treatments for the symptoms of COVID-19 holds promise for preventing disease and extending life for patients with COVID-19. Experts at the forefront of research and development will discuss current standings and projections for COVID-19 vaccines and therapies, and will address some of the most pressing questions around the future of R&D for COVID-19.

This session will incorporate live polling, presented by the Harris Poll. This interactive feature is available for registered participants only.

Moderator

Meg Tirrell

Biotech and Pharma Reporter, CNBC

 

Speakers

Michelle McMurry-Heath

President and CEO, Biotechnology Innovation Organization

Mark Suzman

CEO, Bill & Melinda Gates Foundation

Janet Woodcock

Senior Advisor, Food and Drug Administration

 

Published